U

Ultimovacs ASA
OSE:ULTI

Watchlist Manager
Ultimovacs ASA
OSE:ULTI
Watchlist
Price: 14.5 NOK 0.69% Market Closed
Market Cap: 293.3m NOK
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ULTI Price Targets Summary
Ultimovacs ASA

There are no price targets for ULTI.
ULTI Lowest Forecast
Wall Street Target
Not Available
ULTI Average Forecast
Wall Street Target
Not Available
ULTI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ultimovacs ASA Competitors:
Price Targets
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
29% Upside
PRQR
ProQR Therapeutics NV
350% Upside
IDYA
IDEAYA Biosciences Inc
44% Upside
ATRA
Atara Biotherapeutics Inc
16% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
29% Upside
PRQR
ProQR Therapeutics NV
350% Upside
IDYA
IDEAYA Biosciences Inc
44% Upside
ATRA
Atara Biotherapeutics Inc
16% Upside
KURA
Kura Oncology Inc
217% Upside
AVCT
Avacta Group PLC
56% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
BMEA
Biomea Fusion Inc
441% Upside

Revenue
Forecast

Revenue Estimate
Ultimovacs ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ultimovacs ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ultimovacs ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
56%
Average Beat
What are analyst estimates?

See Also

Summary
ULTI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ULTI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ULTI stock valuation using valuation multiples.
Wall Street Estimates
ULTI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ULTI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ULTI's stock price target?
Not Available

ULTI doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 305,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.